News

Explore the standout moments and expert insights from Dermatology Times' Cutaneous Connection podcast episodes in 2024.

Discover the most impactful insights and expert advice from Dermatology Times' 2024 Interview Intersection column.

As 2024 comes to a close, Dermatology Times is taking a look back at the unique insights and updates shared by nurse practitioners and physician assistants.

As 2024 comes to a close, Dermatology Times is taking a look back at the studies and clinical research from the year.

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in skin cancer this year.

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in acne this year.

Find out what the top 10 most popular articles of 2024 were from Dermatology Times.

Catch up on Dermatology Times conference coverage from July through December of this year.

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in hidradenitis suppurativa this year.

Catch up on coverage of FDA-approved drugs in the second half of 2024.

Explore the top dermatology news of 2024, highlighting breakthroughs, innovations, and key clinical insights shaping the future of skin care and treatment.

Catch up on Dermatology Times conference coverage from January through June of this year.

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in atopic dermatitis this year.

Catch up on coverage of FDA-approved drugs in the first half of 2024.

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in aesthetic/cosmetic dermatology this year.

As 2023 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in psoriasis this year.

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in vitiligo this year.

Deucravacitinib achieved ACR20 response in patients with PsA at week 16, with a safety profile consistent with previous studies.

Dermatology Times is looking back on the top dermatology news headlines from 2024.

At the inaugural Horizons in Advanced Practice meeting, Dr. Noor highlighted the value of amplifying the voices of physician assistants and nurse practitioners to advance patient care.

Hidradenitis suppurativa requires clinical vigilance, empathy, and the courage to escalate therapy early.

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in prurigo nodularis this year.

Dermatology Times is looking back on the top stories in dermatology that involve strides in skin health equity: addressing disparities for skin of color, women, LGBTQ+ patients, and improving care access.

These promising results align with what was discovered in the single-ascending dose portion of the trial earlier this year.

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in rosacea this year.

Messina, senior VP of Aesthetics R&D at Allergan Aesthetics, highlights key trends shaping the aesthetic medicine landscape in 2025.

As 2024 comes to a close, Dermatology Times is taking a look back at the studies, treatment, and advances in chronic hand eczema this year.

In case you missed it, this week we had news about tapinarof’s FDA approval in AD patients 2 and older, new ICD-10 codes for CCCA and FFA, a phase 2 study of INF904, and more.

Renata Block, MMS, PA-C; Ted Lain, MD, MBA, FAAD; Zoe Diana Draelos, MD; and Cheri Frey, MD, FAAD, bust common skin care myths in a Dermatology Times custom video series.

Dermatology Times is looking back on the top stories in dermatology from the month of December.